The Combination of Sinusoidal Perfusion Enhancement and Apoptosis Inhibition by Riociguat Plus a Galactose-PEGylated Bilirubin Multiplexing Nanomedicine Ameliorates Liver Fibrosis Progression-Reference-Cited by-同舟云学术

The Combination of Sinusoidal Perfusion Enhancement and Apoptosis Inhibition by Riociguat Plus a Galactose-PEGylated Bilirubin Multiplexing Nanomedicine Ameliorates Liver Fibrosis Progression

Published:2023-05-08 Issue:10 Volume:23 Page:4126-4135
ISSN:1530-6984
Container-title:Nano Letters
language:en
Short-container-title:Nano Lett.

Author:

Li Fenfen¹²³^ORCID,Cheng Zhaoxia¹²⁴,Sun Jingyi¹²,Cheng Xiaoyu¹²,Li Chen¹²,Wu Zhouliang¹²,Qi Feilong¹²,Zhao Ying¹²,Nie Guangjun¹²⁵^ORCID

Affiliation:

1. CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, China

2. Center of Materials Science and Optoelectronics Engineering, University of Chinese Academy of Sciences, Beijing 100049, China

3. School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China

4. College of Chemistry, Zhengzhou University, Zhengzhou 450001, China

5. GBA Research Innovation Institute for Nanotechnology, Guangzhou 510530, China

Funder

Guangdong Science and Technology Department

Natural Science Foundation of Beijing Municipality

National Natural Science Foundation of China

Beijing Nova Program

Chinese Academy of Sciences

Publisher

American Chemical Society (ACS)

Subject

Mechanical Engineering,Condensed Matter Physics,General Materials Science,General Chemistry,Bioengineering

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.nanolett.2c04726

Reference31 articles.

1. Hepatic macrophages act as a central hub for relaxin-mediated alleviation of liver fibrosis

2. Molecular and cellular mechanisms of liver fibrosis and its regression

3. TNF‐α‐Induce Protein 8–Like 1 Inhibits Hepatic Steatosis, Inflammation, and Fibrosis by Suppressing Polyubiquitination of Apoptosis Signal–Regulating Kinase 1

4. Therapeutic targets, novel drugs, and delivery systems for diabetes associated NAFLD and liver fibrosis

5. Role of inflammatory response in liver diseases: Therapeutic strategies

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sequential system based on ferritin delivery system and cell therapy for modulating the pathological microenvironment and promoting recovery;International Journal of Pharmaceutics;2024-10

2. Adaptive Size Evolution of an MOFs-in-MOF Nanovehicle for Enhanced Nucleus-Targeted Tumor Chemotherapy;Nano Letters;2024-08-15

3. Delivery Strategy to Enhance the Therapeutic Efficacy of Liver Fibrosis via Nanoparticle Drug Delivery Systems;ACS Nano;2024-07-31

4. Engineered liposomes targeting hepatic stellate cells overcome pathological barriers and reverse liver fibrosis;Journal of Controlled Release;2024-04

5. Hepatic Stellate Cell‐Targeting Micelle Nanomedicine for Early Diagnosis and Treatment of Liver Fibrosis;Advanced Healthcare Materials;2024-02-11